Daily Judi: Wednesday, August 24, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Scientists are concerned about the recent discovery of poliovirus in wastewater in London, New York, and Israel, with two active cases reported. This version of poliovirus is a mutation of a broadly used oral vaccine that contains live, weakened virus. (Nature)
Fierce Biotech details the leading global research and development institutes of 2021. Its list includes Stanford University, French National Centre for Scientific Research, and the Max Planck Society, among others.
Meanwhile, BioPharma Dive, looks at the growth and evolution of RNA technology, and the many biotech startups intending to create next-generation therapies using RNA molecules, potentially creating new treatments for rare diseases, cancer, and chronic illness.
The CNS Summit 2022 will be held in Boca Raton, Florida, on November 17–20. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team Judi will be there!
We also hope to see you this September 13-14, at the Westin Copley Place, in Boston, for DPHARM: Disruptive Innovations to Advance Clinical Trials, walking distance from our North End headquarters.
Our Culture
“We work proactively with each client, analyzing our reports to make them work faster, to help make our client’s life better.”
–Tim, Trial Delivery
About Judi
Judi is on a mission to empower the ecosystems that drive clinical trial success by improving their workflows. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.